Neurizon Therapeutics LTD.
Michael Thurn, CEO and Managing Director of Neurizon Therapeutics, joins the OTCQB Podcast to discuss the company's mission to develop treatments for neurodegenerative diseases, highlighting their lead program targeting ALS.